Atletik Performans, Genetik ve Gen Dopingi

ÇİFTCİ, İsmail Can; BIYIKLI, TÜRKER

Atletik Performans, Genetik ve Gen Dopingi

İsmail Can ÇİFTCİ, (İstanbul Üniversitesi Tıp Fakültesi)

Türker BIYIKLI (Gelişim Üniversitesi Beden Eğitimi ve Spor Yüksekokulu, Antrenörlük Bölümü)

İstanbul Kanuni Sultan Süleyman Tıp Dergisi

11 2

Yıl: 2015 Cilt: 7 Sayı: 2 Sayfa Aralığı: 58 - 62 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Atletik Performans, Genetik ve Gen Dopingi

Öz:

Genom bilimi ve gen regülasyonu teknolojilerindeki gelişmeler, bilim insanlarına genetik hastalıkların tedavisinde yeni yöntemlerin geliştirilmesini sağlamıştır. Günümüzde mutasyonlu genin bulunduğu dokuya, genin tam ve çalışan formunu aktarmak olası hâle gelmiştir. Bu disipline "gen tedavisi" denmektedir. Bu yaklaşımın yanında, etki dışı uygulamalar ile sporcularda atletik performansı artırmak amacı ile performans artırıcı genlerin regülasyonları manipüle edilebilir. Bu alt- disipline ise "gen dopingi" adı verilmektedir. Bu uygulamanın en önemli özelliği, ilaç dopinginin aksine, tanısındaki zorluktur. Bu derlemede, kısaca, gen dopingine, gen dopingi metotlarına, aday genlere, olası tanı metotlarına, dezavantajlarına ve Dünya Anti-doping Merkezi'nin rolüne değinilecektir.

Anahtar Kelime:

Konular: Cerrahi

Atletic Performance, Genetics and Gene Doping

Öz:

Advances in genomic era and improvements in gene regulation technology lead scientists to treat genetic human diseases. It is now possible to introduce the intact gene into the tissues in which the mutated form of the gene is present. This discipline is called as "gene therapy". Despite this success, gene therapy may be unethically manipulated to provide enhancement in athletic performance for athletes, by regulating the performance-related genes. This subdiscipline is called as "gene doping". The most important characteristic of gene doping lies in the difficulty of making a diagnosis, unlike drug- based doping. This review briefly addresses the gene doping, methods, candidate genes, possible detection methods, disadvantages and the role of World Anti-doping Agency in gene doping.

Anahtar Kelime:

Konular: Cerrahi

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Bouchard C, Dionne F, Simoneau F, Boulay M. Genetics of aerobic and an-aerobic performances. Exerc. Sport Sci Rev 1992;20:27-58.
2. Yang N, MacArthur DG, Gulbin JP, Hahn AG, Beggs AH, Easteal S, North K. ACTN3 genotype is associated with human elite athletic performance. Am J Hum Genet 2003;73(3):627-31. http://dx.doi.org/10.1086/377590
3. Montgomery HE, Marshall R, Hemingway H, Myerson S, Clarkson P, Dollery C, et al. Human gene for physical performance. Nature 1998;393(6682): 221-2. http://dx.doi.org/10.1038/30374
4. Ulucan K, Göle S, Altindas N, Güney A. Preliminary findings of ? -Actinin-3 gene distribution in elite Turkish wind surfers. Balkan J Med Genet 2013; 16(1) 69-72. http://dx.doi.org/10.2478/bjmg-2013-0020
5. Gunel T, Gumusoglu E, Hosseini MK, Yilmazyildirim E, Dolekcap I, Aydinli K. Effect of angiotensin I-converting enzyme and ?-actinin-3 gene polymorphisms on sport performance. Mol Med Rep 2014;9(4): 1422-6. http://dx.doi.org/10.3892/mmr.2014.1974
6. Ulucan K, Göle S. ACE I/D Polymorphism determination in Turkish elite wind-surfers. Sport Science Review 2014;23(1-2):79-84. http://dx.doi.org/10.2478/ssr-2014-0005
7. Ulucan K, Bayyurt GM, Konuk M, Güney AI. Effect of alpha-actinin-3 gene on Turkish trained and untrained middle school children's sprinting performance: a pilot study. Biological Rhythm Research 2014;45(4): 509-14. http://dx.doi.org/10.1080/09291016.2013.867628
8. Ulucan K, Yalçın S, Akbaş B, Uyumaz F, Muhsin Konuk. Analysis of solute carrier family 6 member 4 gene promoter polymorpism in young Turkish basketball players. The Journal of Neurobehavioral Sciences 2014;1(2):37-40.
9. Wells DJ. Gene doping: possibilities and practicalities. Med Sport Sci 2009;54:166-75. http://dx.doi.org/10.1159/000235703
10. Tural Ş, Tural E, Kara N, Ağaoğlu SA. Gene doping in sport. Selcuk University Journal of Physical Education and Sport Science 2011;13(3):253-60.
11. Azzazy HM, Mansour MM, Christenson RH. Doping in the recombinant era: strategies and counterstrategies. Clin Biochem 2005;38:959-65. http://dx.doi.org/10.1016/j.clinbiochem.2005.09.007
12. John SMG, Noble MA, Lewis DL, Herweijer H, Wolff JA. Progress toward a nonviral gene therapy protocol fort he treatment of anemia. Hum Gene Ther 2007;18:269-85. http://dx.doi.org/10.1089/hum.2006.186
13. Dias RG. Genetics, human physical performance and gene doping: the common sense versus the scientific reality. Rev Bras Med Esporte 2011;17(1):62-70. http://dx.doi.org/10.1590/S1517-86922011000100012
14. Siren AL, Fratelli M, Brines M, Goemans C, Casagrande S, Lewczuk P, et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress". Proc Natl Acad Sci USA 2001;98(7): 4044-9. http://dx.doi.org/10.1073/pnas.051606598
15. Haroon ZA, Amin K, Jiang X, Arcasoy MO. A novel role for erythropoietin during fibrin-induced woundhealing response". Am J Pathol 2003;163(3):993-1000. http://dx.doi.org/10.1016/S0002-9440(10)63459-1
16. Keating GM. Mecasermin. BioDrugs 2008;22(3): 177-88. http://dx.doi.org/10.2165/00063030-200822030-00004
17. Delafontaine P, Song YH, Li Y. "Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels". Arterioscler Thromb Vasc Biol 2005;24(3):435-44. http://dx.doi.org/10.1161/01.ATV.0000105902.89459.09
18. Harridge SDR, Velloso CP. IGF-1 and GH: potential use in gene doping. Growth Horm IGF Res 2009;19: 378-82. http://dx.doi.org/10.1016/j.ghir.2009.04.016
19. Baoutina A, Alexander IE, Rasko JE, Emslie KR. Potential use of gene transfer in athletic performance enhancement. Mol Ther 2007;15(10):1751-66. http://dx.doi.org/10.1038/sj.mt.6300278
20. Martinek V, Fu FH, Huard J. Gene therapy and tissue engineering in sports medicine. Phys Sportsmed 2000; 28(2):1-12. http://dx.doi.org/10.3810/psm.2000.02.691
21. Haisma HJ, Hon O de. Gene doping. Int J Sports Med 2006;27:257-66. http://dx.doi.org/10.1055/s-2006-923986
22. Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal N, Sweeney HL. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci USA 1998;95(26):15603-7. http://dx.doi.org/10.1073/pnas.95.26.15603
23. McKanna TA, Toriello HV. Gene doping: The hype and the harm. Pediatr Clin N Am 2010;57:719-27. http://dx.doi.org/10.1016/j.pcl.2010.02.006

APA	ÇİFTCİ İ, BIYIKLI T (2015). Atletik Performans, Genetik ve Gen Dopingi. , 58 - 62.
Chicago	ÇİFTCİ İsmail Can,BIYIKLI TÜRKER Atletik Performans, Genetik ve Gen Dopingi. (2015): 58 - 62.
MLA	ÇİFTCİ İsmail Can,BIYIKLI TÜRKER Atletik Performans, Genetik ve Gen Dopingi. , 2015, ss.58 - 62.
AMA	ÇİFTCİ İ,BIYIKLI T Atletik Performans, Genetik ve Gen Dopingi. . 2015; 58 - 62.
Vancouver	ÇİFTCİ İ,BIYIKLI T Atletik Performans, Genetik ve Gen Dopingi. . 2015; 58 - 62.
IEEE	ÇİFTCİ İ,BIYIKLI T "Atletik Performans, Genetik ve Gen Dopingi." , ss.58 - 62, 2015.
ISNAD	ÇİFTCİ, İsmail Can - BIYIKLI, TÜRKER. "Atletik Performans, Genetik ve Gen Dopingi". (2015), 58-62.

APA	ÇİFTCİ İ, BIYIKLI T (2015). Atletik Performans, Genetik ve Gen Dopingi. İstanbul Kanuni Sultan Süleyman Tıp Dergisi, 7(2), 58 - 62.
Chicago	ÇİFTCİ İsmail Can,BIYIKLI TÜRKER Atletik Performans, Genetik ve Gen Dopingi. İstanbul Kanuni Sultan Süleyman Tıp Dergisi 7, no.2 (2015): 58 - 62.
MLA	ÇİFTCİ İsmail Can,BIYIKLI TÜRKER Atletik Performans, Genetik ve Gen Dopingi. İstanbul Kanuni Sultan Süleyman Tıp Dergisi, vol.7, no.2, 2015, ss.58 - 62.
AMA	ÇİFTCİ İ,BIYIKLI T Atletik Performans, Genetik ve Gen Dopingi. İstanbul Kanuni Sultan Süleyman Tıp Dergisi. 2015; 7(2): 58 - 62.
Vancouver	ÇİFTCİ İ,BIYIKLI T Atletik Performans, Genetik ve Gen Dopingi. İstanbul Kanuni Sultan Süleyman Tıp Dergisi. 2015; 7(2): 58 - 62.
IEEE	ÇİFTCİ İ,BIYIKLI T "Atletik Performans, Genetik ve Gen Dopingi." İstanbul Kanuni Sultan Süleyman Tıp Dergisi, 7, ss.58 - 62, 2015.
ISNAD	ÇİFTCİ, İsmail Can - BIYIKLI, TÜRKER. "Atletik Performans, Genetik ve Gen Dopingi". İstanbul Kanuni Sultan Süleyman Tıp Dergisi 7/2 (2015), 58-62.